188 related articles for article (PubMed ID: 11157892)
1. Sildenafil-mediated reduction in retinal function in heterozygous mice lacking the gamma-subunit of phosphodiesterase.
Behn D; Potter MJ
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):523-7. PubMed ID: 11157892
[TBL] [Abstract][Full Text] [Related]
2. Visual short-term effects of Viagra: double-blind study in healthy young subjects.
Jägle H; Jägle C; Sérey L; Yu A; Rilk A; Sadowski B; Besch D; Zrenner E; Sharpe LT
Am J Ophthalmol; 2004 May; 137(5):842-9. PubMed ID: 15126148
[TBL] [Abstract][Full Text] [Related]
3. Ribozyme knockdown of the gamma-subunit of rod cGMP phosphodiesterase alters the ERG and retinal morphology in wild-type mice.
Liu J; Timmers AM; Lewin AS; Hauswirth WW
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3836-44. PubMed ID: 16186371
[TBL] [Abstract][Full Text] [Related]
4. Sildenafil (Viagra) evokes retinal arteriolar dilation: dual pathways via NOS activation and phosphodiesterase inhibition.
Yuan Z; Hein TW; Rosa RH; Kuo L
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):720-5. PubMed ID: 18235020
[TBL] [Abstract][Full Text] [Related]
5. The cyclic GMP-specific phosphodiesterase inhibitor, sildenafil, stimulates human sperm motility and capacitation but not acrosome reaction.
Lefièvre L; De Lamirande E; Gagnon C
J Androl; 2000; 21(6):929-37. PubMed ID: 11105920
[TBL] [Abstract][Full Text] [Related]
6. Sildenafil alters retinal function in mouse carriers of retinitis pigmentosa.
Nivison-Smith L; Zhu Y; Whatham A; Bui BV; Fletcher EL; Acosta ML; Kalloniatis M
Exp Eye Res; 2014 Nov; 128():43-56. PubMed ID: 25239397
[TBL] [Abstract][Full Text] [Related]
7. Effect of PDE5 inhibition combined with free oxygen radical scavenger therapy on erectile function in a diabetic animal model.
De Young L; Yu D; Freeman D; Brock GB
Int J Impot Res; 2003 Oct; 15(5):347-54. PubMed ID: 14562136
[TBL] [Abstract][Full Text] [Related]
8. Effects of phosphodiesterase type 5 inhibitor sildenafil on retinal function in isolated superfused retina.
Lüke M; Lüke C; Hescheler J; Schneider T; Sickel W
J Ocul Pharmacol Ther; 2005 Aug; 21(4):305-14. PubMed ID: 16117694
[TBL] [Abstract][Full Text] [Related]
9. Visual halos after sildenafil (Viagra).
Potter MJ; Behn D
Ophthalmology; 2002 May; 109(5):823; author reply 823-4. PubMed ID: 11986069
[No Abstract] [Full Text] [Related]
10. Type 5 phosphodiesterase inhibitors in the treatment of erectile dysfunction and cardiovascular disease.
Ravipati G; McClung JA; Aronow WS; Peterson SJ; Frishman WH
Cardiol Rev; 2007; 15(2):76-86. PubMed ID: 17303994
[TBL] [Abstract][Full Text] [Related]
11. Short- and long-term effects of sildenafil on skin flap survival in rats.
Hart K; Baur D; Hodam J; Lesoon-Wood L; Parham M; Keith K; Vazquez R; Ager E; Pizarro J
Laryngoscope; 2006 Apr; 116(4):522-8. PubMed ID: 16585853
[TBL] [Abstract][Full Text] [Related]
12. Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity.
Fisher PW; Salloum F; Das A; Hyder H; Kukreja RC
Circulation; 2005 Apr; 111(13):1601-10. PubMed ID: 15811867
[TBL] [Abstract][Full Text] [Related]
13. Sildenafil potentiates nitric oxide mediated inhibition of human platelet aggregation.
Gudmundsdóttir IJ; McRobbie SJ; Robinson SD; Newby DE; Megson IL
Biochem Biophys Res Commun; 2005 Nov; 337(1):382-5. PubMed ID: 16185664
[TBL] [Abstract][Full Text] [Related]
14. Sildenafil inhibits beta-adrenergic-stimulated cardiac contractility in humans.
Borlaug BA; Melenovsky V; Marhin T; Fitzgerald P; Kass DA
Circulation; 2005 Oct; 112(17):2642-9. PubMed ID: 16246964
[TBL] [Abstract][Full Text] [Related]
15. Systemic administration of phosphodiesterase V inhibitor, sildenafil citrate, for attenuation of cerebral vasospasm after experimental subarachnoid hemorrhage.
Atalay B; Caner H; Cekinmez M; Ozen O; Celasun B; Altinors N
Neurosurgery; 2006 Nov; 59(5):1102-7; discussion 1107-8. PubMed ID: 17143244
[TBL] [Abstract][Full Text] [Related]
16. Effects of phosphodiesterase 5 inhibitor on pulmonary vascular reactivity in the fetal lamb.
Jaillard S; Larrue B; Deruelle P; Delelis A; Rakza T; Butrous G; Storme L
Ann Thorac Surg; 2006 Mar; 81(3):935-42. PubMed ID: 16488698
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of serotonin transport by the cyclic GMP phosphodiesterase-5 inhibitor sildenafil.
Zhu CB; Hewlett WA; Francis SH; Corbin JD; Blakely RD
Eur J Pharmacol; 2004 Nov; 504(1-2):1-6. PubMed ID: 15507214
[TBL] [Abstract][Full Text] [Related]
18. The effect of sildenafil on ocular blood flow.
Harris A; Kagemann L; Ehrlich R; Ehrlich Y; López CR; Purvin VA
Br J Ophthalmol; 2008 Apr; 92(4):469-73. PubMed ID: 18369062
[TBL] [Abstract][Full Text] [Related]
19. Cardioprotection with sildenafil, a selective inhibitor of cyclic 3',5'-monophosphate-specific phosphodiesterase 5.
Das S; Maulik N; Das DK; Kadowitz PJ; Bivalacqua TJ
Drugs Exp Clin Res; 2002; 28(6):213-9. PubMed ID: 12776574
[TBL] [Abstract][Full Text] [Related]
20. Differential inhibitor sensitivity between human recombinant and native photoreceptor cGMP-phosphodiesterases (PDE6s).
Zhang J; Kuvelkar R; Wu P; Egan RW; Billah MM; Wang P
Biochem Pharmacol; 2004 Sep; 68(5):867-73. PubMed ID: 15294449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
